2000-Patient study aims to predict which IBD treatments work best
NCT ID NCT07166588
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study is collecting health information from 2000 people with Crohn's disease or ulcerative colitis to create tools that predict how well different treatments will work. The goal is to help doctors choose the right biologic or small-molecule drug for each patient. Participants are aged 10 and older and are being recruited from three hospitals in South Korea.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD-INFLAMMATORY BOWEL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.